R1 RCM acquires Humata Health
Analysis based on 8 articles · First reported Aug 18, 2026 · Last updated Aug 18, 2026
The acquisition is expected to strengthen R1 RCM's competitive position in the healthcare revenue cycle management market by adding advanced AI capabilities, potentially increasing its market share and customer value. For Humata Health, the deal provides access to R1's extensive provider network and operational scale, likely accelerating its growth and adoption.
R1 RCM, a healthcare revenue management company, announced on August 18, 2026, that it has entered into an agreement to acquire Humata Health, a provider of AI-powered, touchless prior authorization technology. The acquisition is intended to enhance R1's Phare Operating System (Phare OS) by integrating Humata's agentic AI capabilities, which automate the prior authorization process, reducing administrative burden and improving reimbursement accuracy. Financial terms were not disclosed. The transaction is expected to close by the end of the third quarter of 2026, after which Humata's team will join R1's R37 innovation lab. Humata's technology reportedly achieves up to a 96% first-pass approval rate and reduces write-offs by 30%, rescheduled appointments by 83%, and staff touches by 45%. The deal aligns with R1's strategy to automate the revenue cycle and move toward real-time authorizations, a goal supported by upcoming federal interoperability mandates. Humata's investors include Blue Venture Fund, Sandbox Clinical Venture Fund, LRVHealth, 406 Ventures, and Highmark Ventures, with Lazard serving as financial advisor.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard